Target Details
| UniProt AC | P49841 |
|---|---|
| Gene Symbol | GSK3B |
| Protein Name | Glycogen synthase kinase-3 beta |
| Organism | Homo sapiens |
| Entry Name | |
| Organism Category | Human |
| Pfam Domains | PF00069 (Pkinase) |
Summary
- Multi-target molecules 2,206
- Clinical molecules 168
- Avg pChEMBL 7.19
KEGG Pathways (49)
- Alcoholic liver disease
- Alzheimer disease
- Axon guidance
- B cell receptor signaling pathway
- Basal cell carcinoma
- Breast cancer
- Cadherin signaling
- Cell cycle
- Chemokine signaling pathway
- Colorectal cancer
- Cushing syndrome
- Diabetic cardiomyopathy
- Dopaminergic synapse
- EGFR tyrosine kinase inhibitor resistance
- Endometrial cancer
- ErbB signaling pathway
- Focal adhesion
- Gastric cancer
- Growth hormone synthesis, secretion and action
- Hedgehog signaling pathway
- Hepatitis C
- Hepatocellular carcinoma
- Hippo signaling pathway
- Human cytomegalovirus infection
- Human papillomavirus infection
- IL-17 signaling pathway
- IgSF CAM signaling
- Insulin resistance
- Insulin signaling pathway
- Integrin signaling
- Kaposi sarcoma-associated herpesvirus infection
- Lipid and atherosclerosis
- Measles
- Melanogenesis
- Neurotrophin signaling pathway
- Non-alcoholic fatty liver disease
- PI3K-Akt signaling pathway
- Pathways in cancer
- Pathways of neurodegeneration - multiple diseases
- Prion disease
- Prolactin signaling pathway
- Prostate cancer
- Shigellosis
- Signaling pathways regulating pluripotency of stem cells
- T cell receptor signaling pathway
- Thyroid hormone signaling pathway
- Wnt signaling pathway
- Yersinia infection
- mTOR signaling pathway
Active Molecules (2,206)
| InChIKey | pChEMBL | Type | Targets | Clinical | |
|---|---|---|---|---|---|
BFTPXDHXFOTGDU
|
6.3 | IC50 | 2 | — | |
BHLCWTAXFPUMBK
|
6.3 | IC50 | 3 | — | |
BIYAZNGCRGXNLF
|
6.3 | IC50 | 2 | — | |
BQANCCJQDVDSMZ
|
6.3 | IC50 | 2 | — | |
BQXKIEGCTZNZJF
|
6.3 | IC50 | 2 | — | |
BRWLQOMUQLZXCS
|
6.3 | IC50 | 2 | — | |
BSCYKVQKPPMWMR
|
6.3 | IC50 | 2 | — | |
BSWQXWOCAIDEBD
|
6.3 | IC50 | 2 | — | |
CAKMXCJFQDYCIQ
|
6.3 | IC50 | 3 | — | |
CFHSYCUITBKSNH
|
6.3 | IC50 | 2 | — | |
CGSUIIMKMMBVDX
|
6.3 | IC50 | 2 | — | |
CJCQWOYOQUKTSL
|
6.3 | IC50 | 2 | — | |
CKXADPBXKBNOPA
|
6.3 | IC50 | 2 | — | |
CLFYUFLXZKKWNJ
|
6.3 | IC50 | 2 | — | |
CNUBKTDOCIEBDF
|
6.3 | IC50 | 2 | — | |
CTMTZOCLGOODKV
|
6.3 | IC50 | 2 | — | |
CUPZXMGQKPMVSB
|
6.3 | IC50 | 2 | — | |
DAVFGXNRKYKZHG
|
6.3 | IC50 | 2 | — | |
DBFYDGPTRXUUSV
|
6.3 | IC50 | 2 | — | |
DCOBHVJIWWKDNC
|
6.3 | IC50 | 2 | — | |
DKVRBIUPGOOJBI
|
6.3 | IC50 | 2 | — | |
DLUGKTFVHTXBSB
|
6.3 | IC50 | 2 | — | |
DMBJHTAPQWJGTP
|
6.3 | IC50 | 2 | — | |
DPIHEJDXZNGKOI
|
6.3 | IC50 | 2 | — | |
DPKWEPQBVKHUQT
|
6.3 | IC50 | 4 | — | |
DRSYNBCQUXRNAS
|
6.3 | IC50 | 2 | — | |
DRSYNBCQUXRNAS
|
6.3 | IC50 | 2 | — | |
DURKJRKBCQPMHX
|
6.3 | IC50 | 2 | — | |
DVROSIRXAJGZQJ
|
6.3 | IC50 | 2 | — | |
DWTMUHDGBKOJPU
|
6.3 | IC50 | 2 | — | |
DYHWNWZUHIVXKJ
|
6.3 | IC50 | 2 | — | |
DZEQFHQPKUESHF
|
6.3 | IC50 | 2 | — | |
FCMYFDMCVMPKBP
|
6.3 | IC50 | 2 | — | |
FCMYFDMCVMPKBP
|
6.3 | IC50 | 3 | — | |
FFFWFAUFYUNHEL
|
6.3 | IC50 | 2 | — | |
FFUVAFCOXULBHS
|
6.3 | IC50 | 2 | — | |
FJNLORLHCYMBBR
|
6.3 | IC50 | 2 | — | |
FJUIOPHFIQWVDW
|
6.3 | IC50 | 2 | — | |
FLDJOJYJBVOMIJ
|
6.3 | IC50 | 2 | — | |
FMSMZAINGJZVQX
|
6.3 | IC50 | 2 | — | |
FMZIEOFMQVXRHN
|
6.3 | IC50 | 2 | — | |
FQNITDDDUQQKBZ
|
6.3 | IC50 | 2 | — | |
FTGDQWVTFMVQFU
|
6.3 | IC50 | 2 | — | |
FUXOZIAGSVPZOA
|
6.3 | IC50 | 2 | — | |
FXKIQUHSILISAN
|
6.3 | IC50 | 2 | — | |
FYILYHLJTFZUSX
|
6.3 | IC50 | 2 | — | |
GDYMYOAYQVMSFW
|
6.3 | IC50 | 2 | — | |
GEKDLEORXAMOED
|
6.3 | IC50 | 2 | — | |
GFMIVIFSMXHDSU
|
6.3 | IC50 | 2 | — | |
GGCDUHHRRANMCC
|
6.3 | IC50 | 2 | — |